Search

FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs

Dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg.  Stelfonta is injected directly into the MCT (intratumoral injection). Stelfonta works by activating a…

Read More

On National Dog Day, Nissan shares pet safety tips!

National Dog Day

The all-new Nissan Rogue is engineered to make family life easier, including families with fur kids NASHVILLE, Tenn. – Join Nissan in celebration of National Dog Day on Aug. 26 with a pledge to help keep your pets safe when traveling by car. In a recent study1, Nissan found that due to COVID-19, 71 percent of consumers are more comfortable…

Read More